Loading…

TTCOV19: timing of tracheotomy in SARS-CoV-2-infected patients: a multicentre, single-blinded, randomized, controlled trial

Background Critically ill COVID-19 patients may develop acute respiratory distress syndrome and the need for respiratory support, including mechanical ventilation in the intensive care unit. Previous observational studies have suggested early tracheotomy to be advantageous. The aim of this parallel,...

Full description

Saved in:
Bibliographic Details
Published in:Critical Care 2022, Vol.26 (1)
Main Authors: Eeg-Olofsson, Måns, Pauli, Nina, Hafsten, Louise, Jacobsson, Josephine, Lundborg, Christopher, Brink, Magnus, Larsson, Helen, Lindell, Ellen, Löwhagen, Karin, Gisslén, Magnus, Bergquist, Henrik
Format: Report
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 1
container_start_page
container_title Critical Care
container_volume 26
creator Eeg-Olofsson, Måns
Pauli, Nina
Hafsten, Louise
Jacobsson, Josephine
Lundborg, Christopher
Brink, Magnus
Larsson, Helen
Lindell, Ellen
Löwhagen, Karin
Gisslén, Magnus
Bergquist, Henrik
description Background Critically ill COVID-19 patients may develop acute respiratory distress syndrome and the need for respiratory support, including mechanical ventilation in the intensive care unit. Previous observational studies have suggested early tracheotomy to be advantageous. The aim of this parallel, multicentre, single-blinded, randomized controlled trial was to evaluate the optimal timing of tracheotomy. Methods SARS-CoV-2-infected patients within the Region Västra Götaland of Sweden who needed intubation and mechanical respiratory support were included and randomly assigned to early tracheotomy ([less than or equai to] 7 days after intubation) or late tracheotomy ([greater than or equai to] 10 days after intubation). The primary objective was to compare the total number of mechanical ventilation days between the groups. Results One hundred fifty patients (mean age 65 years, 79% males) were included. Seventy-two patients were assigned to early tracheotomy, and 78 were assigned to late tracheotomy. One hundred two patients (68%) underwent tracheotomy of whom sixty-one underwent tracheotomy according to the protocol. The overall median number of days in mechanical ventilation was 18 (IQR 9; 28), but no significant difference was found between the two treatment regimens in the intention-to-treat analysis (between-group difference: - 1.5 days (95% CI - 5.7 to 2.8); p = 0.5). A significantly reduced number of mechanical ventilation days was found in the early tracheotomy group during the per-protocol analysis (between-group difference: - 8.0 days (95% CI - 13.8 to - 2.27); p = 0.0064). The overall correlation between the timing of tracheotomy and days of mechanical ventilation was significant (Spearman's correlation: 0.39, p < 0.0001). The total death rate during intensive care was 32.7%, but no significant differences were found between the groups regarding survival, complications or adverse events. Conclusions The potential superiority of early tracheotomy when compared to late tracheotomy in critically ill patients with COVID-19 was not confirmed by the present randomized controlled trial but is a strategy that should be considered in selected cases where the need for MV for more than 14 days cannot be ruled out. Trial registrationNCT04412356, registered 05/24/2020. Graphic abstract Keywords: COVID-19, Mechanical ventilation, Intensive care, Time factors, Tracheotomy
doi_str_mv 10.1186/s13054-022-04005-0
format report
fullrecord <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracacademiconefile_A704300466</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A704300466</galeid><sourcerecordid>A704300466</sourcerecordid><originalsourceid>FETCH-gale_infotracacademiconefile_A7043004663</originalsourceid><addsrcrecordid>eNqVjk1OAzEMhbMAifJzAVY5QFOcSSYduqtGIHaV6KhbFCaeYpQfNAkL4PKkEhdAXjy_J3-2GbuVsJKyM3dZKmi1gKYRoAFaAWdsIZXRomtVe8Euc34HkOvOqAX7GYZ-d5D3G14oUDzyNPEy2_ENU0nhi1Pk--3zXvTpIBpBccKxoOMfthDGkjfc8vDpC43Vzbjkue7wKF49RYduyWcbXQr0ferHVGeS95UvM1l_zc4n6zPe_OkVWz0-DP2TOFqPL_VWOn1Sy2GgCuNENd-uQSsAbYz6N_ALt1BaWA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>report</recordtype></control><display><type>report</type><title>TTCOV19: timing of tracheotomy in SARS-CoV-2-infected patients: a multicentre, single-blinded, randomized, controlled trial</title><source>Open Access: PubMed Central</source><source>ProQuest - Publicly Available Content Database</source><creator>Eeg-Olofsson, Måns ; Pauli, Nina ; Hafsten, Louise ; Jacobsson, Josephine ; Lundborg, Christopher ; Brink, Magnus ; Larsson, Helen ; Lindell, Ellen ; Löwhagen, Karin ; Gisslén, Magnus ; Bergquist, Henrik</creator><creatorcontrib>Eeg-Olofsson, Måns ; Pauli, Nina ; Hafsten, Louise ; Jacobsson, Josephine ; Lundborg, Christopher ; Brink, Magnus ; Larsson, Helen ; Lindell, Ellen ; Löwhagen, Karin ; Gisslén, Magnus ; Bergquist, Henrik</creatorcontrib><description>Background Critically ill COVID-19 patients may develop acute respiratory distress syndrome and the need for respiratory support, including mechanical ventilation in the intensive care unit. Previous observational studies have suggested early tracheotomy to be advantageous. The aim of this parallel, multicentre, single-blinded, randomized controlled trial was to evaluate the optimal timing of tracheotomy. Methods SARS-CoV-2-infected patients within the Region Västra Götaland of Sweden who needed intubation and mechanical respiratory support were included and randomly assigned to early tracheotomy ([less than or equai to] 7 days after intubation) or late tracheotomy ([greater than or equai to] 10 days after intubation). The primary objective was to compare the total number of mechanical ventilation days between the groups. Results One hundred fifty patients (mean age 65 years, 79% males) were included. Seventy-two patients were assigned to early tracheotomy, and 78 were assigned to late tracheotomy. One hundred two patients (68%) underwent tracheotomy of whom sixty-one underwent tracheotomy according to the protocol. The overall median number of days in mechanical ventilation was 18 (IQR 9; 28), but no significant difference was found between the two treatment regimens in the intention-to-treat analysis (between-group difference: - 1.5 days (95% CI - 5.7 to 2.8); p = 0.5). A significantly reduced number of mechanical ventilation days was found in the early tracheotomy group during the per-protocol analysis (between-group difference: - 8.0 days (95% CI - 13.8 to - 2.27); p = 0.0064). The overall correlation between the timing of tracheotomy and days of mechanical ventilation was significant (Spearman's correlation: 0.39, p &lt; 0.0001). The total death rate during intensive care was 32.7%, but no significant differences were found between the groups regarding survival, complications or adverse events. Conclusions The potential superiority of early tracheotomy when compared to late tracheotomy in critically ill patients with COVID-19 was not confirmed by the present randomized controlled trial but is a strategy that should be considered in selected cases where the need for MV for more than 14 days cannot be ruled out. Trial registrationNCT04412356, registered 05/24/2020. Graphic abstract Keywords: COVID-19, Mechanical ventilation, Intensive care, Time factors, Tracheotomy</description><identifier>ISSN: 1364-8535</identifier><identifier>DOI: 10.1186/s13054-022-04005-0</identifier><language>eng</language><publisher>BioMed Central Ltd</publisher><subject>Care and treatment ; Comparative analysis ; Critically ill ; Patient outcomes ; Tracheotomy</subject><ispartof>Critical Care, 2022, Vol.26 (1)</ispartof><rights>COPYRIGHT 2022 BioMed Central Ltd.</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>776,780,4476,27901</link.rule.ids></links><search><creatorcontrib>Eeg-Olofsson, Måns</creatorcontrib><creatorcontrib>Pauli, Nina</creatorcontrib><creatorcontrib>Hafsten, Louise</creatorcontrib><creatorcontrib>Jacobsson, Josephine</creatorcontrib><creatorcontrib>Lundborg, Christopher</creatorcontrib><creatorcontrib>Brink, Magnus</creatorcontrib><creatorcontrib>Larsson, Helen</creatorcontrib><creatorcontrib>Lindell, Ellen</creatorcontrib><creatorcontrib>Löwhagen, Karin</creatorcontrib><creatorcontrib>Gisslén, Magnus</creatorcontrib><creatorcontrib>Bergquist, Henrik</creatorcontrib><title>TTCOV19: timing of tracheotomy in SARS-CoV-2-infected patients: a multicentre, single-blinded, randomized, controlled trial</title><title>Critical Care</title><description>Background Critically ill COVID-19 patients may develop acute respiratory distress syndrome and the need for respiratory support, including mechanical ventilation in the intensive care unit. Previous observational studies have suggested early tracheotomy to be advantageous. The aim of this parallel, multicentre, single-blinded, randomized controlled trial was to evaluate the optimal timing of tracheotomy. Methods SARS-CoV-2-infected patients within the Region Västra Götaland of Sweden who needed intubation and mechanical respiratory support were included and randomly assigned to early tracheotomy ([less than or equai to] 7 days after intubation) or late tracheotomy ([greater than or equai to] 10 days after intubation). The primary objective was to compare the total number of mechanical ventilation days between the groups. Results One hundred fifty patients (mean age 65 years, 79% males) were included. Seventy-two patients were assigned to early tracheotomy, and 78 were assigned to late tracheotomy. One hundred two patients (68%) underwent tracheotomy of whom sixty-one underwent tracheotomy according to the protocol. The overall median number of days in mechanical ventilation was 18 (IQR 9; 28), but no significant difference was found between the two treatment regimens in the intention-to-treat analysis (between-group difference: - 1.5 days (95% CI - 5.7 to 2.8); p = 0.5). A significantly reduced number of mechanical ventilation days was found in the early tracheotomy group during the per-protocol analysis (between-group difference: - 8.0 days (95% CI - 13.8 to - 2.27); p = 0.0064). The overall correlation between the timing of tracheotomy and days of mechanical ventilation was significant (Spearman's correlation: 0.39, p &lt; 0.0001). The total death rate during intensive care was 32.7%, but no significant differences were found between the groups regarding survival, complications or adverse events. Conclusions The potential superiority of early tracheotomy when compared to late tracheotomy in critically ill patients with COVID-19 was not confirmed by the present randomized controlled trial but is a strategy that should be considered in selected cases where the need for MV for more than 14 days cannot be ruled out. Trial registrationNCT04412356, registered 05/24/2020. Graphic abstract Keywords: COVID-19, Mechanical ventilation, Intensive care, Time factors, Tracheotomy</description><subject>Care and treatment</subject><subject>Comparative analysis</subject><subject>Critically ill</subject><subject>Patient outcomes</subject><subject>Tracheotomy</subject><issn>1364-8535</issn><fulltext>true</fulltext><rsrctype>report</rsrctype><creationdate>2022</creationdate><recordtype>report</recordtype><sourceid/><recordid>eNqVjk1OAzEMhbMAifJzAVY5QFOcSSYduqtGIHaV6KhbFCaeYpQfNAkL4PKkEhdAXjy_J3-2GbuVsJKyM3dZKmi1gKYRoAFaAWdsIZXRomtVe8Euc34HkOvOqAX7GYZ-d5D3G14oUDzyNPEy2_ENU0nhi1Pk--3zXvTpIBpBccKxoOMfthDGkjfc8vDpC43Vzbjkue7wKF49RYduyWcbXQr0ferHVGeS95UvM1l_zc4n6zPe_OkVWz0-DP2TOFqPL_VWOn1Sy2GgCuNENd-uQSsAbYz6N_ALt1BaWA</recordid><startdate>20220518</startdate><enddate>20220518</enddate><creator>Eeg-Olofsson, Måns</creator><creator>Pauli, Nina</creator><creator>Hafsten, Louise</creator><creator>Jacobsson, Josephine</creator><creator>Lundborg, Christopher</creator><creator>Brink, Magnus</creator><creator>Larsson, Helen</creator><creator>Lindell, Ellen</creator><creator>Löwhagen, Karin</creator><creator>Gisslén, Magnus</creator><creator>Bergquist, Henrik</creator><general>BioMed Central Ltd</general><scope/></search><sort><creationdate>20220518</creationdate><title>TTCOV19: timing of tracheotomy in SARS-CoV-2-infected patients: a multicentre, single-blinded, randomized, controlled trial</title><author>Eeg-Olofsson, Måns ; Pauli, Nina ; Hafsten, Louise ; Jacobsson, Josephine ; Lundborg, Christopher ; Brink, Magnus ; Larsson, Helen ; Lindell, Ellen ; Löwhagen, Karin ; Gisslén, Magnus ; Bergquist, Henrik</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-gale_infotracacademiconefile_A7043004663</frbrgroupid><rsrctype>reports</rsrctype><prefilter>reports</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Care and treatment</topic><topic>Comparative analysis</topic><topic>Critically ill</topic><topic>Patient outcomes</topic><topic>Tracheotomy</topic><toplevel>online_resources</toplevel><creatorcontrib>Eeg-Olofsson, Måns</creatorcontrib><creatorcontrib>Pauli, Nina</creatorcontrib><creatorcontrib>Hafsten, Louise</creatorcontrib><creatorcontrib>Jacobsson, Josephine</creatorcontrib><creatorcontrib>Lundborg, Christopher</creatorcontrib><creatorcontrib>Brink, Magnus</creatorcontrib><creatorcontrib>Larsson, Helen</creatorcontrib><creatorcontrib>Lindell, Ellen</creatorcontrib><creatorcontrib>Löwhagen, Karin</creatorcontrib><creatorcontrib>Gisslén, Magnus</creatorcontrib><creatorcontrib>Bergquist, Henrik</creatorcontrib></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Eeg-Olofsson, Måns</au><au>Pauli, Nina</au><au>Hafsten, Louise</au><au>Jacobsson, Josephine</au><au>Lundborg, Christopher</au><au>Brink, Magnus</au><au>Larsson, Helen</au><au>Lindell, Ellen</au><au>Löwhagen, Karin</au><au>Gisslén, Magnus</au><au>Bergquist, Henrik</au><format>book</format><genre>unknown</genre><ristype>RPRT</ristype><atitle>TTCOV19: timing of tracheotomy in SARS-CoV-2-infected patients: a multicentre, single-blinded, randomized, controlled trial</atitle><jtitle>Critical Care</jtitle><date>2022-05-18</date><risdate>2022</risdate><volume>26</volume><issue>1</issue><issn>1364-8535</issn><abstract>Background Critically ill COVID-19 patients may develop acute respiratory distress syndrome and the need for respiratory support, including mechanical ventilation in the intensive care unit. Previous observational studies have suggested early tracheotomy to be advantageous. The aim of this parallel, multicentre, single-blinded, randomized controlled trial was to evaluate the optimal timing of tracheotomy. Methods SARS-CoV-2-infected patients within the Region Västra Götaland of Sweden who needed intubation and mechanical respiratory support were included and randomly assigned to early tracheotomy ([less than or equai to] 7 days after intubation) or late tracheotomy ([greater than or equai to] 10 days after intubation). The primary objective was to compare the total number of mechanical ventilation days between the groups. Results One hundred fifty patients (mean age 65 years, 79% males) were included. Seventy-two patients were assigned to early tracheotomy, and 78 were assigned to late tracheotomy. One hundred two patients (68%) underwent tracheotomy of whom sixty-one underwent tracheotomy according to the protocol. The overall median number of days in mechanical ventilation was 18 (IQR 9; 28), but no significant difference was found between the two treatment regimens in the intention-to-treat analysis (between-group difference: - 1.5 days (95% CI - 5.7 to 2.8); p = 0.5). A significantly reduced number of mechanical ventilation days was found in the early tracheotomy group during the per-protocol analysis (between-group difference: - 8.0 days (95% CI - 13.8 to - 2.27); p = 0.0064). The overall correlation between the timing of tracheotomy and days of mechanical ventilation was significant (Spearman's correlation: 0.39, p &lt; 0.0001). The total death rate during intensive care was 32.7%, but no significant differences were found between the groups regarding survival, complications or adverse events. Conclusions The potential superiority of early tracheotomy when compared to late tracheotomy in critically ill patients with COVID-19 was not confirmed by the present randomized controlled trial but is a strategy that should be considered in selected cases where the need for MV for more than 14 days cannot be ruled out. Trial registrationNCT04412356, registered 05/24/2020. Graphic abstract Keywords: COVID-19, Mechanical ventilation, Intensive care, Time factors, Tracheotomy</abstract><pub>BioMed Central Ltd</pub><doi>10.1186/s13054-022-04005-0</doi></addata></record>
fulltext fulltext
identifier ISSN: 1364-8535
ispartof Critical Care, 2022, Vol.26 (1)
issn 1364-8535
language eng
recordid cdi_gale_infotracacademiconefile_A704300466
source Open Access: PubMed Central; ProQuest - Publicly Available Content Database
subjects Care and treatment
Comparative analysis
Critically ill
Patient outcomes
Tracheotomy
title TTCOV19: timing of tracheotomy in SARS-CoV-2-infected patients: a multicentre, single-blinded, randomized, controlled trial
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-24T07%3A33%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.atitle=TTCOV19:%20timing%20of%20tracheotomy%20in%20SARS-CoV-2-infected%20patients:%20a%20multicentre,%20single-blinded,%20randomized,%20controlled%20trial&rft.jtitle=Critical%20Care&rft.au=Eeg-Olofsson,%20M%C3%A5ns&rft.date=2022-05-18&rft.volume=26&rft.issue=1&rft.issn=1364-8535&rft_id=info:doi/10.1186/s13054-022-04005-0&rft_dat=%3Cgale%3EA704300466%3C/gale%3E%3Cgrp_id%3Ecdi_FETCH-gale_infotracacademiconefile_A7043004663%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A704300466&rfr_iscdi=true